首頁 › 食道癌 › 密西根 › Grand Rapids
Grand Rapids, MI 的 食道癌 臨床試驗
14 項針對 食道癌 的研究正在 Grand Rapids（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
招募中1 期
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
招募中歡迎健康志工
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Pan-tumor MRD Study
招募中觀察性研究
- The Cancer & Hematology Centers (CHC), Grand Rapids
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
招募中1 期
- BAMF Health Inc., Grand Rapids
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
招募中1 期
- BAMF Health Inc., Grand Rapids
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- START Midwest, Grand Rapids
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
招募中觀察性研究
- Cancer & Hematology Centers of Western Michigan, Grand Rapids
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
招募中3 期
- Research Site, Grand Rapids
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
招募中1/2 期
- The Cancer and Hematology Centers ( Site 8912), Grand Rapids
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
招募中1/2 期
- The Cancer and Hematology Centers ( Site 6912), Grand Rapids
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
招募中1 期
- START Midwest /ID# 248685, Grand Rapids
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
招募中1/2 期
- START Midwest, Grand Rapids
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
招募中1/2 期
- BAMF Health, Inc., Grand Rapids
其他城市的 食道癌 試驗
- Houston, TX36 項研究
- Boston, MA23 項研究
- New York City, NY22 項研究
- Nashville, TN19 項研究
- St. Louis, MO17 項研究
- Pittsburgh, PA15 項研究
- Los Angeles, CA15 項研究
- Baldwin Park, CA14 項研究
- Philadelphia, PA13 項研究
- San Antonio, TX12 項研究
- Dallas, TX11 項研究
- Chicago, IL11 項研究
Grand Rapids 的其他研究
- 非小細胞肺癌44 項研究
- 大腸直腸癌40 項研究
- 癌症（所有類型）28 項研究
- 乳癌26 項研究
- 卵巢癌24 項研究
- 轉移性癌症22 項研究
- 前列腺癌19 項研究
- 子宮內膜癌18 項研究
- 胃癌18 項研究
- 胰臟癌18 項研究
- 黑色素瘤17 項研究
- 頭頸部鱗狀細胞癌15 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。